Display options
Cite
Bertaina A, Zorzoli A, Petretto A, et al. Zoledronic acid boosts γδ T-cell activity in children receiving αβ. Oncoimmunology. 2016;6(2):e1216291doi: 10.1080/2162402X.2016.1216291.
Bertaina, A., Zorzoli, A., Petretto, A., Barbarito, G., Inglese, E., Merli, P., Lavarello, C., Brescia, L. P., De Angelis, B., Tripodi, G., Moretta, L., Locatelli, F., & Airoldi, I. (2017). Zoledronic acid boosts γδ T-cell activity in children receiving αβ. Oncoimmunology, 6(2), e1216291. https://doi.org/10.1080/2162402X.2016.1216291
Bertaina, A, et al. "Zoledronic acid boosts γδ T-cell activity in children receiving αβ." Oncoimmunology vol. 6,2 (2017): e1216291. doi: https://doi.org/10.1080/2162402X.2016.1216291
Bertaina A, Zorzoli A, Petretto A, Barbarito G, Inglese E, Merli P, Lavarello C, Brescia LP, De Angelis B, Tripodi G, Moretta L, Locatelli F, Airoldi I. Zoledronic acid boosts γδ T-cell activity in children receiving αβ. Oncoimmunology. 2016 Sep 27;6(2):e1216291. doi: 10.1080/2162402X.2016.1216291. eCollection 2017. PMID: 28344861; PMCID: PMC5353934.
Copy Download .nbib Format: NLM
Share it on

Oncoimmunology. 2016 Sep 27;6(2):e1216291. doi: 10.1080/2162402X.2016.1216291. eCollection 2017.

Zoledronic acid boosts γδ T-cell activity in children receiving αβ.

Oncoimmunology

A Bertaina, A Zorzoli, A Petretto, G Barbarito, E Inglese, P Merli, C Lavarello, L P Brescia, B De Angelis, G Tripodi, L Moretta, F Locatelli, I Airoldi

Affiliations

  1. Department of Pediatric Hematology and Oncology, IRCCS Ospedale Bambino Gesù , Rome, Italy.
  2. Laboratorio di Oncologia, Istituto Giannina Gaslini , Genova, Italy.
  3. Core Facilities, Istituto Giannina Gaslini , Genova, Italy.
  4. Dipartimento Ricerca Traslazionale, Medicina di Laboratorio, Diagnostica e Servizi, Istituto Giannina Gaslini , Genova, Italy.
  5. Area di Ricerca Immunologica, IRCCS Ospedale Bambino Gesù , Rome, Italy.
  6. Department of Pediatric Hematology and Oncology, IRCCS Ospedale Bambino Gesù, Rome, Italy; Department of Pediatric Science, Università di Pavia, Pavia, Italy.

PMID: 28344861 PMCID: PMC5353934 DOI: 10.1080/2162402X.2016.1216291

Abstract

We demonstrated that γδ T cells of patients given HLA-haploidentical HSCT after removal of αβ

Keywords: haematopoietic stem cell transplantation; leukemic patients; proteomic; zoledronic acid; γδ T cells

References

  1. J Clin Oncol. 2002 Sep 1;20(17):3719-36 - PubMed
  2. Clin Immunol. 2009 Dec;133(3):422-7 - PubMed
  3. Blood. 2011 Aug 4;118(5):1402-12 - PubMed
  4. J Exp Med. 2003 Aug 4;198(3):391-7 - PubMed
  5. Biochim Biophys Acta. 2010 Nov;1802(11):1078-86 - PubMed
  6. Mol Cell Proteomics. 2014 Dec;13(12):3410-20 - PubMed
  7. Nat Methods. 2013 Oct;10(10):989-91 - PubMed
  8. J Proteome Res. 2013 Jun 7;12(6):2858-68 - PubMed
  9. Nat Commun. 2016 Jan 04;7:10259 - PubMed
  10. Blood. 1997 May 15;89(10):3864-72 - PubMed
  11. Oncoimmunology. 2012 Dec 1;1(9):1614-1616 - PubMed
  12. Leukemia. 2013 Jun;27(6):1328-38 - PubMed
  13. Stat Med. 1999 Mar 30;18(6):695-706 - PubMed
  14. J Clin Oncol. 2010 Aug 1;28(22):3548-51 - PubMed
  15. Mol Cell. 2013 Feb 21;49(4):583-90 - PubMed
  16. Blood. 2015 Apr 9;125(15):2349-58 - PubMed
  17. Eur J Immunol. 2005 Jun;35(6):1764-72 - PubMed
  18. Nat Methods. 2014 Mar;11(3):319-24 - PubMed
  19. Br J Haematol. 1993 Apr;83(4):602-7 - PubMed
  20. Bioinformatics. 2009 Apr 15;25(8):1091-3 - PubMed
  21. Mol Immunol. 2011 May;48(9-10):1203-8 - PubMed
  22. J Immunol. 2015 Jun 15;194(12):5736-42 - PubMed
  23. J Clin Oncol. 2005 Nov 10;23(32):8219-24 - PubMed
  24. J Clin Invest. 1999 May 15;103(10):1437-49 - PubMed
  25. Proc Natl Acad Sci U S A. 2014 Dec 16;111(50):17995-8000 - PubMed
  26. Front Immunol. 2014 Dec 17;5:645 - PubMed
  27. J Clin Oncol. 2005 May 20;23(15):3447-54 - PubMed
  28. Science. 2002 Mar 15;295(5562):2097-100 - PubMed
  29. Blood. 2003 Jul 1;102(1):200-6 - PubMed
  30. Bone Marrow Transplant. 2007 Jun;39(12):751-7 - PubMed
  31. Oncoimmunology. 2013 Mar 1;2(3):e23304 - PubMed
  32. Blood. 2010 Sep 23;116(12):2164-72 - PubMed
  33. Pediatr Blood Cancer. 2011 Aug;57(2):275-82 - PubMed
  34. Blood. 2004 Sep 15;104(6):1801-7 - PubMed
  35. Blood. 2014 Jul 31;124(5):822-6 - PubMed
  36. Mol Immunol. 2011 Oct;49(1-2):4-7 - PubMed
  37. Transpl Int. 2011 May;24(5):e40-2 - PubMed
  38. Nat Rev Immunol. 2013 Feb;13(2):88-100 - PubMed
  39. Mol Cell Biol. 2007 Mar;27(5):1947-59 - PubMed
  40. Clin Exp Immunol. 2010 Aug;161(2):290-7 - PubMed
  41. Proc Natl Acad Sci U S A. 2009 Feb 17;106(7):2307-12 - PubMed
  42. Mol Cell Proteomics. 2013 Nov;12(11):3330-8 - PubMed
  43. Nat Rev Immunol. 2010 Jul;10(7):467-78 - PubMed
  44. J Leukoc Biol. 2013 Dec;94(6):1141-57 - PubMed
  45. J Hematother. 1996 Oct;5(5):503-9 - PubMed
  46. Cytotherapy. 2013 Oct;15(10):1253-8 - PubMed
  47. Blood. 2003 Sep 15;102(6):2310-1 - PubMed
  48. Science. 2002 Mar 22;295(5563):2255-8 - PubMed

Publication Types